Xue-Bin Wang1, Ning-Hua Cui2, Jia-Jia Gao1, Xue-Ping Qiu1, Fang Zheng3. 1. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China. 2. Department of Clinical Laboratory, Zhengzhou Children's Hospital, Zhengzhou 450053, Henan, China. 3. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China. Electronic address: zhengfang@whu.edu.cn.
Abstract
OBJECTIVE: To investigate the association between SMN1 and SMN2 copy number variations (CNVs) and sporadic amyotrophic lateral sclerosis (SALS) by a meta-analysis. METHODS: Through searching PubMed and EMBASE database (or manual searching) up to November 2013 using the following keywords: "survival motor neuron gene", "SMN", and "amyotrophic lateral sclerosis", "ALS" or "motor neuron disease". Nine studies were identified as eligible for this meta-analysis. The association between SMN genes and the SALS risk was investigated based on SMN1 and SMN2 CNVs. The heterogeneity across the studies was tested, as was publication bias. RESULTS: The analysis showed significant association for SMN1 duplications in SALS risk: the risk estimates were OR=1.76, 95%CI=1.33-2.32, p<0.0001 (still significant when the p value was Bonferroni adjusted to 0.01). However, there was no significant association between SMN1 deletions and SALS risk after Bonferroni correction (OR=1.78, 95%CI=1.02-3.11, p=0.04). In addition, SMN2 copy number statuses were not associated with SALS in our pooled study. No evidence of publication bias was observed. CONCLUSION: Our meta-analysis suggested that SMN1 duplications are a genetic risk factor in SALS, while there was no modulator effect of the SMN2 gene. In addition, it was possible that SMN1 deletions in predisposition to SALS vary across different countries. More studies were required to warrant the findings of this study.
OBJECTIVE: To investigate the association between SMN1 and SMN2 copy number variations (CNVs) and sporadic amyotrophic lateral sclerosis (SALS) by a meta-analysis. METHODS: Through searching PubMed and EMBASE database (or manual searching) up to November 2013 using the following keywords: "survival motor neuron gene", "SMN", and "amyotrophic lateral sclerosis", "ALS" or "motor neuron disease". Nine studies were identified as eligible for this meta-analysis. The association between SMN genes and the SALS risk was investigated based on SMN1 and SMN2 CNVs. The heterogeneity across the studies was tested, as was publication bias. RESULTS: The analysis showed significant association for SMN1 duplications in SALS risk: the risk estimates were OR=1.76, 95%CI=1.33-2.32, p<0.0001 (still significant when the p value was Bonferroni adjusted to 0.01). However, there was no significant association between SMN1 deletions and SALS risk after Bonferroni correction (OR=1.78, 95%CI=1.02-3.11, p=0.04). In addition, SMN2 copy number statuses were not associated with SALS in our pooled study. No evidence of publication bias was observed. CONCLUSION: Our meta-analysis suggested that SMN1 duplications are a genetic risk factor in SALS, while there was no modulator effect of the SMN2 gene. In addition, it was possible that SMN1 deletions in predisposition to SALS vary across different countries. More studies were required to warrant the findings of this study.
Authors: Natalia Rodriguez-Muela; Nadia K Litterman; Erika M Norabuena; Jesse L Mull; Maria José Galazo; Chicheng Sun; Shi-Yan Ng; Nina R Makhortova; Andrew White; Maureen M Lynes; Wendy K Chung; Lance S Davidow; Jeffrey D Macklis; Lee L Rubin Journal: Cell Rep Date: 2017-02-07 Impact factor: 9.423
Authors: Lucio Tremolizzo; Gessica Sala; Elisa Conti; Virginia Rodriguez-Menendez; Antonella Fogli; Angela Michelucci; Paolo Simi; Silvana Penco; Christian Lunetta; Massimo Corbo; Carlo Ferrarese Journal: Case Rep Neurol Med Date: 2014-07-17
Authors: Jan Veldink; Philip Van Damme; Matthieu Moisse; Ramona A J Zwamborn; Joke van Vugt; Rick van der Spek; Wouter van Rheenen; Brendan Kenna; Kristel Van Eijk; Kevin Kenna; Philippe Corcia; Philippe Couratier; Patrick Vourc'h; Orla Hardiman; Russell McLaughin; Marc Gotkine; Vivian Drory; Nicola Ticozzi; Vincenzo Silani; Mamede de Carvalho; Jesús S Mora Pardina; Monica Povedano; Peter M Andersen; Markus Weber; Nazli A Başak; Xiao Chen; Michael A Eberle; Ammar Al-Chalabi; Chris Shaw; Pamela J Shaw; Karen E Morrison; John E Landers; Jonathan D Glass; Wim Robberecht; Michael van Es; Leonard van den Berg Journal: Ann Neurol Date: 2021-01-15 Impact factor: 10.422
Authors: Jeroen W Bos; Ewout J N Groen; Renske I Wadman; Chantall A D Curial; Naomi N Molleman; Marinka Zegers; Paul W J van Vught; Reinier Snetselaar; Raymon Vijzelaar; W Ludo van der Pol; Leonard H van den Berg Journal: Neurol Genet Date: 2021-06-22